Asia-Pacific Coronavirus Test Kits Market Report 2021 - Market is Poised to Decline by $2.48 Billion to 2025, Progressing at a CAGR of -17%

Dublin, June 28, 2021 (GLOBE NEWSWIRE) -- The "Coronavirus Test Kits Market in APAC 2021-2025" report has been added to's offering.

The APAC coronavirus test kits market is poised to decline by $2.48 bn during 2021-2025, progressing at a CAGR of over -17%

The market is driven by the increasing incidence of coronavirus and new product launches.

The report on coronavirus test kits market in APAC provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current APAC market scenario, latest trends and drivers, and the overall market environment. The coronavirus test kits market in APAC analysis includes end-user segment and geographic landscape.

This study identifies the government initiative in creating awareness about coronavirus as one of the prime reasons driving the coronavirus test kits market in APAC growth during the next few years.

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coronavirus test kits market in APAC vendors that include 3D Biomedicine Science and Technology Co. Ltd., Abbott , BGI Genomics Co. Ltd., Co Diagnostics Inc., F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Maccura Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt Ltd., QIAGEN NV, and Thermo Fisher Scientific .

Also, the coronavirus test kits market in APAC analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Key Topics Covered:

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Government - Market size and forecast 2020-2025
  • Non-government - Market size and forecast 2020-2025

Customer landscape

  • Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • India - Market size and forecast 2020-2025
  • China - Market size and forecast 2020-2025
  • Japan - Market size and forecast 2020-2025
  • South Korea (Republic of Korea) - Market size and forecast 2020-2025
  • Rest of APAC - Market size and forecast 2020-2025
  • Market opportunity by geography

Drivers Challenges and Trends

  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • 3D Biomedicine Science and Technology Co. Ltd.
  • Abbott
  • BGI Genomics Co. Ltd.
  • Co Diagnostics Inc.
  • F. Hoffmann La Roche Ltd.
  • Guangzhou Wondfo Biotech Co. Ltd.
  • Maccura Biotechnology Co. Ltd.
  • Mylab Discovery Solutions Pvt Ltd.
  • Thermo Fisher Scientific .


For more information about this report visit

         Laura Wood,  Senior  Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900